$LGND LIGAND PHARMACEUTICALS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in LIGAND PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in LIGAND PHARMACEUTICALS INC for free.

CIK Number: 0000886163
IRS Number: 770160744
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: LGND
Company Address: 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO 92121
Phone number: 858-550-7500

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Market Capitalization: $2.24B
Prev close: $107.84
Average Daily Volume: 309,645
Days Low: $106.18
Year Low: $82.06
Year High: $139.79

LIGAND PHARMACEUTICALS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Davis Todd CDirector47,6785,141,596shares bought: 29,121 / shares sold: -33,875 SELLFeb 12 20213 months ago
KOZARICH JOHN WDirector29,7083,203,711shares bought: 8,940 / shares sold: -29,516 STRONG SELLFeb 23 20213 months ago

View all LIGAND PHARMACEUTICALS INC insiders.

LIGAND PHARMACEUTICALS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 23 2021LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorOption ExerciseM10.122,50025,3004,835
Feb 23 2021LGNDLIGAND PHARMACEUTI ...KOZARICH JOHN WDirectorBuyM10.122,50025,30029,70827.2 K to 29.7 K (+9.19 %)
Feb 12 2021LGNDLIGAND PHARMACEUTI ...Davis Todd CDirectorOption ExerciseM195.912,474484,6810
Feb 12 2021LGNDLIGAND PHARMACEUTI ...Davis Todd CDirectorBuyM195.912,474484,68150,15247.7 K to 50.2 K (+5.19 %)
Feb 12 2021LGNDLIGAND PHARMACEUTI ...Davis Todd CDirectorSellS213.145,0831,083,41047,67852.8 K to 47.7 K (-9.63 %)
Feb 09 2021LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LChief Executive Off ...Option ExerciseM14.4754,666791,01714,334
Feb 09 2021LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LChief Executive Off ...Option ExerciseM10.0560,000603,0000
Feb 09 2021LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LChief Executive Off ...Payment of ExerciseF203.032,970602,999343,060346 K to 343.1 K (-0.86 %)
Feb 09 2021LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LChief Executive Off ...BuyM10.0560,000603,000346,030286 K to 346 K (+20.98 %)
Feb 09 2021LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LChief Executive Off ...SellS203.4054,66611,119,239286,030340.7 K to 286 K (-16.05 %)
Feb 09 2021LGNDLIGAND PHARMACEUTI ...HIGGINS JOHN LChief Executive Off ...BuyM14.4754,666791,017340,696286 K to 340.7 K (+19.11 %)
Feb 05 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...Option ExerciseA177.506,9551,234,5136,955
Feb 05 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...SellS178.5018,0973,230,37628,90647 K to 28.9 K (-38.50 %)
Feb 05 2021LGNDLIGAND PHARMACEUTI ...Berkman Charles SSVP, Gen. Counsel & ...GrantA0.003,491047,00343.5 K to 47 K (+8.02 %)
Feb 05 2021LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WPresident and COOOption ExerciseA177.5013,1362,331,64013,136

View all LIGAND PHARMACEUTICALS INC insider transactions.